Gritstone bio to showcase evaluations of self-amplifying mRNA (samRNA) against SARS-CoV-2 at ECCMID 2023.

Both presentations are from the company’s CORAL program, which is evaluating various self-amplifying mRNA (samRNA) vaccine candidates targeting Spike...

April 05, 2023 | Wednesday | News
NRG Therapeutics Announces International Scientific Advisory Board

The four founding members of NRG’s International SAB are US-based and bring in-depth translational expertise in neuroscience and drug discovery acros...

March 30, 2023 | Thursday | News
Willow Biosciences Announces Changes to Board and Management

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing indust...

March 29, 2023 | Wednesday | News
Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board

Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potenti...

March 28, 2023 | Tuesday | News
Cellusion Transplants First iPSC-Derived Corneal Endothelial Cell Substitute (CLS001) in Patient

Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., "Cellusion") announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health Univer...

March 28, 2023 | Tuesday | News
ABL appoints Stéphanie Colloud as general manager and chief operating officer to lead European activities

ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development and manufacturing of solutions fo...

March 27, 2023 | Monday | News
Premier Health amends circular and announces shareholder meeting results

Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announce...

March 26, 2023 | Sunday | News
Theriva Biologics Reschedules Conference Call to Discuss Q4 and Full-Year 2022 Results

Conference call to be held on Thursday, March 30 at 8:30 a.m. ET Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing ...

March 26, 2023 | Sunday | News
Ordinary and Extraordinary General Meeting of April 12, 2023

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, will hold its Or...

March 26, 2023 | Sunday | News
Abcam's Rich Lane Talks Expansion in APAC Region

What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes that collaboration is a big driver o...

March 26, 2023 | Sunday | Influencers
Enhanced traceability plays a crucial role in building a resilient biopharma supply chain

How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience?  Unpredict...

March 26, 2023 | Sunday | Influencers
ProfoundBio showcases PRO1184's antitumor activity at AACR 2023

ProfoundBio, a clinical stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential, will present t...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close